Serial changes in adiponectin and resistin in critically ill patients with sepsis: Associations with sepsis phase, severity, and circulating cytokine levels

Journal of Critical Care

Volumn 27, Issue 4, 2012, Pages 400-409

  Vassiliadi, Dimitra A ^a   Tzanela, Marinella ^a   Kotanidou, Anastasia ^a   Orfanos, Stylianos E ^b   Nikitas, Nikitas ^b   Armaganidis, Apostolos ^b   Koutsilieris, Michalis ^c   Roussos, Charis ^a   Tsagarakis, Stylianos ^b   Dimopoulou, Ioanna ^b  

^a EVANGELISMOS HOSPITAL   (Greece)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Adiponectin; APACHE II score; Cytokines; Resistin; Sepsis; Septic shock; Severe sepsis; SOFA score

Indexed keywords

ADIPONECTIN; CYTOKINE; GLUCOCORTICOID; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; RESISTIN;

ABDOMINAL INFECTION; ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CRITICALLY ILL PATIENT; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PNEUMONIA; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN METABOLISM; SEPSIS; SEPTIC SHOCK;

ADIPONECTIN; ADULT; APACHE; CRITICAL ILLNESS; CYTOKINES; FEMALE; HEALTH STATUS INDICATORS; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; ORGAN DYSFUNCTION SCORES; PROSPECTIVE STUDIES; RESISTIN; SEPSIS; TIME FACTORS;

EID: 84864131567     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2012.04.007     Document Type: Article

References (31)

1. Andersen S.K., Gjedsted J., Christiansen C., et al. The roles of insulin and hyperglycemia in sepsis pathogenesis. J Leukoc Biol 2004, 75:413-421.
2. Vanhorebeek I., Langouche L., Van den Berghe G. Endocrine aspects of acute and prolonged critical illness. Nat Clin Pract Endocrinol Metab 2006, 2:20-31.
3. Tzanela M., Orfanos S.E., Tsirantonaki M., et al. Leptin alterations in the course of sepsis in humans. In Vivo 2006, 20:565-570.
4. Langouche L., Vander Perre S., Frystyk J., et al. Adiponectin, retinol-binding protein 4, and leptin in protracted critical illness of pulmonary origin. Crit Care 2009, 13:R112.
5. Arnalich F., Lopez J., Codoceo R., et al. Relationship of plasma leptin to plasma cytokines and human survival in sepsis and septic shock. J Infect Dis 1999, 180:908-911.
6. Robinson K., Prins J., Venkatesh B. Clinical review: adiponectin biology and its role in inflammation and critical illness. Crit Care 2011, 15:221.
7. Filkova M., Haluzik M., Gay S., et al. The role of resistin as a regulator of inflammation: implications for various human pathologies. Clin Immunol 2009, 133:157-170.
8. Anderson P.D., Mehta N.N., Wolfe M.L., et al. Innate immunity modulates adipokines in humans. J Clin Endocrinol Metab 2007, 92:2272-2279.
9. Teoh H., Quan A., Bang K.W., et al. Adiponectin deficiency promotes endothelial activation and profoundly exacerbates sepsis-related mortality. Am J Physiol Endocrinol Metab 2008, 295:E658-E664.
10. Steppan C.M., Bailey S.T., Bhat S., et al. The hormone resistin links obesity to diabetes. Nature 2001, 409:307-312.
11. Lehrke M., Reilly M.P., Millington S.C., et al. An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med 2004, 1:e45.
12. Park H.K., Qatanani M., Briggs E.R., et al. Inflammatory induction of human resistin causes insulin resistance in endotoxemic mice. Diabetes 2011, 60:775-783.
13. Uji Y., Yamamoto H., Tsuchihashi H., et al. Adiponectin deficiency is associated with severe polymicrobial sepsis, high inflammatory cytokine levels, and high mortality. Surgery 2009, 145:550-557.
14. Keller P., Moller K., Krabbe K.S., et al. Circulating adiponectin levels during human endotoxaemia. Clin Exp Immunol 2003, 134:107-110.
15. Koch A., Gressner O.A., Sanson E., et al. Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients. Crit Care 2009, 13:R95.
16. Koch A., Sanson E., Voigt S., et al. Serum adiponectin upon admission to the intensive care unit may predict mortality in critically ill patients. J Crit Care 2011, 26:166-174.
17. Walkey A.J., Rice T.W., Konter J., et al. Plasma adiponectin and mortality in critically ill subjects with acute respiratory failure. Crit Care Med 2010, 38:2329-2334.
18. Hillenbrand A., Knippschild U., Weiss M., et al. Sepsis induced changes of adipokines and cytokines-septic patients compared to morbidly obese patients. BMC Surg 2010, 10:26.
19. Sunden-Cullberg J., Nystrom T., Lee M.L., et al. Pronounced elevation of resistin correlates with severity of disease in severe sepsis and septic shock. Crit Care Med 2007, 35:1536-1542.
20. Venkatesh B., Hickman I., Nisbet J., et al. Changes in serum adiponectin concentrations in critical illness: a preliminary investigation. Crit Care 2009, 13:R105.
21. Dimopoulou I., Orfanos S.E., Pelekanou A., et al. Serum of patients with septic shock stimulates the expression of Trem-1 on U937 monocytes. Inflamm Res 2009, 58:127-132.
22. Dimopoulou I., Orfanos S., Kotanidou A., et al. Plasma pro- and anti-inflammatory cytokine levels and outcome prediction in unselected critically ill patients. Cytokine 2008, 41:263-267.
23. Bone R.C., Balk R.A., Cerra F.B., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644-1655.
24. Matsuda M., DeFronzo R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999, 22:1462-1470.
25. Kaplan J.M., Denenberg A., Monaco M., et al. Changes in peroxisome proliferator-activated receptor-gamma activity in children with septic shock. Intensive Care Med 2010, 36:123-130.
26. Fallo F., Scarda A., Sonino N., et al. Effect of glucocorticoids on adiponectin: a study in healthy subjects and in Cushing's syndrome. Eur J Endocrinol 2004, 150:339-344.
27. Jernas M., Olsson B., Sjoholm K., et al. Changes in adipose tissue gene expression and plasma levels of adipokines and acute-phase proteins in patients with critical illness. Metabolism 2009, 58:102-108.
28. Saijo S., Nagata K., Nakano Y., et al. Inhibition by adiponectin of IL-8 production by human macrophages upon coculturing with late apoptotic cells. Biochem Biophys Res Commun 2005, 334:1180-1183.
29. Yannakoulia M., Yiannakouris N., Bluher S., et al. Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. J Clin Endocrinol Metab 2003, 88:1730-1736.
30. Lee J.H., Chan J.L., Yiannakouris N., et al. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J Clin Endocrinol Metab 2003, 88:4848-4856.
31. Hillenbrand A., Weiss M., Knippschild U., et al. Association of adiponectin levels and insulin demand in critically ill patients. Diabetes Metab Syndr Obes 2011, 4:45-51.